The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
In vivo monitoring of JAK/STAT and PI3K/mTOR signal transduction inhibition in pediatric CRLF2-rearranged acute lymphoblastic leukemia (ALL).
Sarah Kathleen Tasian
No relevant relationships to disclose
Shannon L. Maude
No relevant relationships to disclose
Junior Hall
No relevant relationships to disclose
Tiffaney Vincent
No relevant relationships to disclose
Charles Grenfell Mullighan
No relevant relationships to disclose
Cheryl L. Willman
No relevant relationships to disclose
Stephen Hunger
No relevant relationships to disclose
Mignon L. Loh
No relevant relationships to disclose
David T. Teachey
No relevant relationships to disclose
Stephan A. Grupp
No relevant relationships to disclose